Literature DB >> 11895355

Functional outcome following salvage of failed trapeziometacarpal joint arthroplasty.

K J Renfree1, P C Dell.   

Abstract

The outcomes in 12 patients who underwent revision surgery for a failed trapeziometacarpal joint arthroplasty were assessed. Multiple procedures were common (an average of 4.5 per patient), and associated with an overall complication rate of 27%. However, after an average follow-up of 5 years, nine of the 12 patients reported improved function and ability to complete normal daily tasks. Most patients were satisfied with their level of pain relief, their grip and pinch strength, and their overall final result. The subjective outcome was less satisfactory in those involved in workers' compensation litigation. All seven attempted scaphoid-thumb metacarpal fusions failed. Copyright 2002 The British Society for Surgery of the Hand.

Entities:  

Mesh:

Year:  2002        PMID: 11895355     DOI: 10.1054/jhsb.2001.0648

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  4 in total

1.  Unplanned Reoperation After Trapeziometacarpal Arthroplasty: Rate, Reasons, and Risk Factors.

Authors:  Suzanne C Wilkens; Zichao Xue; Jos J Mellema; David Ring; Neal Chen
Journal:  Hand (N Y)       Date:  2016-11-15

2.  Trapeziectomy and Alternative Suspension Technique in Thumb Carpometacarpal Arthritis: Patient-Reported Outcome Measures.

Authors:  Cecile M C A van Laarhoven; Sophie Treu; Leonardo C A Claasen; Mark Van Heijl; J Henk Coert; Arnold H Schuurman
Journal:  J Hand Surg Glob Online       Date:  2022-03-26

3.  Revision Ligament Reconstruction Tendon Interposition for Trapeziometacarpal Arthritis: A Case-Control Investigation.

Authors:  Anita Sadhu; Ryan P Calfee; Andre Guthrie; Lindley B Wall
Journal:  J Hand Surg Am       Date:  2016-10-15       Impact factor: 2.230

4.  Revision of trapeziometacarpal arthroplasty: risk factors, procedures and outcomes.

Authors:  Simo Mattila; Eero Waris
Journal:  Acta Orthop       Date:  2019-04-01       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.